Bioethics News

Research Data, Missing for Decades, Raise Concerns for Morning Sickness Drug

January 4, 2017

(STAT News) – The only FDA-approved drug for morning sickness, taken by some 33 million women worldwide since the 1950s, has had a history of ups and downs. A new study adds further uncertainty about the drug. Diclegis, approved by the FDA in 2013, is the rebranded version of an earlier medication called Bendectin. That pill was widely prescribed for more than 50 years, but in the late 1970s, lawsuits began calling into doubt its safety, alleging that the drug caused birth defects.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.